title: Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients.
abstract: BACKGROUND
  Renal transplantation (RT) is considered the treatment of choice for end-stage renal disease compared to dialysis, offering better health-related quality of life (HRQoL) and higher survival rates. However, immunosuppressants are essential for the long-term survival of kidney grafts and patients' non-adherence to their medication leads to poor outcomes. Immunosuppressants can also significantly alter patients' HRQoL because of their side effects and the complex chronic medication regimen they represent.
  
  
  OBJECTIVE
  To elicit key concepts related to adherence to immunosuppressant therapy (IT) and reasons for non-adherence in terms of patient reported outcomes, side effects, and the impact of the medication on HRQoL in RT population, including patient preference of once daily over twice-daily immunosuppressive regimen. Results were used to develop an IT-specific conceptual framework and provide suggestions for improving patients' adherence to IT.
  
  
  METHODS
  Interviews were conducted with three clinical experts to determine key concepts related to RT and immunosuppressants. Thirty-seven participants in four focus groups were asked to cite important concepts related to adherence and impact of IT on HRQoL and to rate them. Qualitative analysis was conducted to code participants' responses.
  
  
  RESULTS
  Non-adherence among participants where admitted was unintentional. The reason for this included forgetfulness, interference with lifestyle, being asleep at the time the medication should be taken, change in routine, and impact of side effects. Overall, participants reported that the evening dose was more problematic to remember and that the exclusion of this dose could make them more adherent. Participants also reported that IT impacted on their HRQoL in a number of ways including: placing restrictions on their lifestyle, causing anxiety, or impairing their ability to work.
  
  
  CONCLUSIONS
  This study provides qualitative evidence about the barriers to IT adherence and the components of HRQoL that are important from the perspective of RT patients. The developed conceptual framework of IT-HRQoL in RT transplants, including social, psychological, and work life domains, can be used to inform the development of a new IT-specific measure of HRQoL in RT patients for use in head-to-head clinical trials or observational studies. Despite limitations associated with the number and the age range of patients recruited, this study suggests that a change in the regimen from twice-daily to once daily among other measures could improve their adherence to IT and their HRQoL by placing less restrictions on their lifestyles.
authors.affiliation: Astellas Pharma Europe Ltd, Chertsey, London, UK.
authors.forename: Gorden
authors.initials: G
authors.lastname: Muduma
authors.affiliation: Creativ-Ceutical Ltd, London, UK.
authors.forename: Francis C
authors.initials: FC
authors.lastname: Shupo
authors.affiliation: Creativ-Ceutical Ltd, Paris, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Dam
authors.affiliation: Creativ-Ceutical Ltd, Paris, France.
authors.forename: Natalia A
authors.initials: NA
authors.lastname: Hawken
authors.affiliation: Creativ-Ceutical Ltd, Paris, France.
authors.forename: Samuel
authors.initials: S
authors.lastname: Aballéa
authors.affiliation: Astellas Pharma Europe Ltd, Chertsey, London, UK.
authors.forename: Isaac
authors.initials: I
authors.lastname: Odeyemi
authors.affiliation: Public Health (EA 3279), Faculty of Medicine, Aix-Marseille University, Marseille, France.
authors.forename: Mondher
authors.initials: M
authors.lastname: Toumi
keywords: PRO; QoL; adherence; conceptual framework; immunosuppressant; renal transplantation
references.citation: Clin Transplant. 2010 Sep-Oct;24(5):709-16
references.pmid: 20047613
references.citation: Ther Clin Risk Manag. 2011;7:149-56
references.pmid: 21691585
references.citation: Transpl Int. 2009 Aug;22(8):780-97
references.pmid: 19386076
references.citation: Clin J Am Soc Nephrol. 2013 Jul;8(7):1258-66
references.pmid: 23559679
references.citation: JAMA. 1993 Sep 15;270(11):1339-43
references.pmid: 8360969
references.citation: Transplantation. 2004 Mar 15;77(5):769-76
references.pmid: 15021846
references.citation: Transplant Proc. 2006 Jun;38(5):1293-4
references.pmid: 16797285
references.citation: Clin Nurse Spec. 2003 Jul;17(4):200-8; quiz 209-30
references.pmid: 12869867
references.citation: J Nephrol. 2010 May-Jun;23(3):274-81
references.pmid: 20383867
references.citation: J Paediatr Child Health. 2015 Feb;51(2):220-2
references.pmid: 25407852
references.citation: Int J Nurs Stud. 2007 Nov;44(8):1468-77
references.pmid: 16973166
references.citation: Transplant Proc. 2011 May;43(4):1020-3
references.pmid: 21620041
references.citation: Psychol Health Med. 2007 Aug;12(4):509-17
references.pmid: 17620214
references.citation: Clin Transplant. 2012 Mar-Apr;26(2):369-76
references.pmid: 22035067
references.citation: Patient Prefer Adherence. 2014 Jan 09;8:73-81
references.pmid: 24470756
references.citation: Patient Prefer Adherence. 2013 Apr 16;7:301-7
references.pmid: 23620661
references.citation: Am J Transplant. 2011 Sep;11(9):1965-71
references.pmid: 21668633
references.citation: Transplantation. 2009 Mar 15;87(5):711-8
references.pmid: 19295316
references.citation: Transpl Int. 2005 Oct;18(10):1121-33
references.pmid: 16162098
references.citation: Qual Life Res. 2003 Mar;12(2):103-15
references.pmid: 12639058
references.citation: BMJ. 1995 Jul 29;311(7000):299-302
references.pmid: 7633241
references.citation: Am J Transplant. 2004 Sep;4(9):1509-13
references.pmid: 15307839
references.citation: J Am Soc Nephrol. 2005 Jun;16(6):1839-48
references.pmid: 15800121
references.citation: Clin J Am Soc Nephrol. 2010 Dec;5(12):2323-8
references.pmid: 20847093
references.citation: Transplant Proc. 2008 Jun;40(5):1362-5
references.pmid: 18589106
references.citation: Transpl Int. 2009 May;22(5):534-45
references.pmid: 19175560
references.citation: JBI Database System Rev Implement Rep. 2015 Sep;13(9):279-308
references.pmid: 26470673
references.citation: Ann Behav Med. 2012 Aug;44(1):85-93
references.pmid: 22454221
references.citation: Transplant Proc. 2005 Mar;37(2):867-70
references.pmid: 15848559
references.citation: Am J Transplant. 2012 Feb;12(2):388-99
references.pmid: 22081892
references.citation: Transplantation. 2013 Jan 27;95(2):333-40
references.pmid: 23263559
references.citation: Coll Antropol. 2011 Sep;35(3):687-93
references.pmid: 22053542